
Sign up to save your podcasts
Or


Today on the Medscape Medical Minute: Only 7% of patients with cancer are getting guideline-recommended germline genetic testing; an experimental drug shows early promise in reducing liver fat in patients with NASH; and UK researchers report that long COVID symptoms are more severe in menopausal women.
By MedscapeToday on the Medscape Medical Minute: Only 7% of patients with cancer are getting guideline-recommended germline genetic testing; an experimental drug shows early promise in reducing liver fat in patients with NASH; and UK researchers report that long COVID symptoms are more severe in menopausal women.